Exosome Diagnostics Inc - Product Pipeline Analysis, 2019 Update

Published by Global Data on 12th November 2019 | Ref: 1463910 | This Product Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Global License
$750 | Single User
$1500 | Site License
$2250 | Global License

Introduction

Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Exosome Diagnostics Inc Company Overview

Exosome Diagnostics Inc Company Snapshot

Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview

Exosome Diagnostics Inc – Pipeline Analysis Overview

Exosome Diagnostics Inc - Key Facts

Exosome Diagnostics Inc - Major Products and Services

Exosome Diagnostics Inc Pipeline Products by Development Stage

Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status

Exosome Diagnostics Inc Pipeline Products Overview

Biofluid Nucleic Acid Kit - Alzheimer's Disease

Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview

Biofluid Nucleic Acid Kit - Cardiovascular Disease

Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview

Biofluid Nucleic Acid Kit - Chronic Kidney Disease

Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview

Biofluid Nucleic Acid Kit - Parkinson's Disease

Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview

Biofluid-Based Molecular Diagnostic Test - Brain Cancer

Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview

BIONIC Liquid Biopsy - Bladder Cancer

BIONIC Liquid Biopsy - Bladder Cancer Product Overview

Diagnostic Test - Neurodegenerative Diseases

Diagnostic Test - Neurodegenerative Diseases Product Overview

ExoDx Lung(EGFR)

ExoDx Lung(EGFR) Product Overview

ExoDx Prostate(IntelliScore) - IVD Version

ExoDx Prostate(IntelliScore) - IVD Version Product Overview

ExoDx Prostate(IntelliScore) - IVD Version Clinical Trial

ExoDx Prostate(IntelliScore) - LDT

ExoDx Prostate(IntelliScore) - LDT Product Overview

Next-Generation Solid Tumor Mutation Panel

Next-Generation Solid Tumor Mutation Panel Product Overview

Shahky

Shahky Product Overview

Exosome Diagnostics Inc - Key Competitors

Exosome Diagnostics Inc - Key Employees

Exosome Diagnostics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Exosome Diagnostics Inc, Recent Developments

Jun 17, 2019: FDA grants breakthrough device designation to Bio-Techne's ExoDx Prostate IntelliScore (EPI) Test

Jun 13, 2019: Bio-Techne receives approval to offer The ExoDx Prostate Intelliscore (EPI) test in New York State

Sep 18, 2018: Bio-Techne announces publication of data demonstrating additional clinical validation of its EPI Test in European Urology Journal

Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification

May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel

May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel

May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA

May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain

May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test

May 08, 2018: Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate(IntelliScore) (EPI) Test

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

Additional Details

Publisher

Global Data

Publisher Information

Reference

1463910 | GDME103113PD

Number of Pages

39

Report Format

PDF

Related Reports

Title
Date Published
Price From
Link

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Exosome Diagnostics Inc - Product Pipeline Analysis, 2019 Update | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.